Seventy-five cirrhotic patients were submitted to peroperative hemodynamic investigations including flow and pressure studies. Sixty-two patients with hepatopedal portal flow underwent a therapeutic end-to-site portacaval shunt (PC) in conjunction with arterialization of the portal vein and 13 with a stagnant flow a PC shunt alone. Thirty-five patients were operated on in emergency and 40 electively. In 61 patients portal flow was correlated with maximum perfusion pressure (r=0.66), and in 33 patients with the reduction of corrected sinusoidal pressure induced by the occlusion of the portal vein (r=0.72). Operative mortality, which was 3.5% for 57 class A and B patients and 55.5% for 18 class C patients, differed significantly (p less than 0.05) in emergency between arterialized (14.8%) and nonarterialized patients (62.5%). At the time this study was ended on July 15, 1981, the follow-up was over two years for all the patients. The five-year actuarial survival rate of the arterialize... 
Seventy-five cirrhotic patients were submitted to peroperative hemodynamic investigations including flow and pressure studies. Sixty-two patients with a hepatopedal portal flow underwent a therapeutic end-to-side portacaval shunt (PC) in conjunction with arterialization of the portal vein and 13 with a stagnant flow a PC shunt alone. Thirty-five patients were operated on in emergency and 40 electively. In 61 patients portal flow was correlated with maximum perfusion pressure (r = 0.66), and in 33 patients with the reduction of corrected sinusoidal pressure induced by the occlusion of the portal vein (r = 0.72). Operative mortality, which was 3.5% for 57 class A and B patients and 55.5% for 18 class C patients, differed significantly (p < 0.05) in emergency between atterialized (14.8%) and nonarterialized patients (62.5%). At the time this study was ended on July 15, 1981 , the follow-up was over two years for all the patients. The five-year actuarial survival rate of the arterialized patients was 48% for the whole group and 56% for class A and B patients; the overall incidence of chronic encephalopathy was 20%. It is concluded that arterialization is a safe surgical procedure that could be beneficial in respect with operative mortality in emergency, late survival, and tolerance to portacaval shunt. However, a prospective randomized study such as the one undertaken in December 1979 is the only method to prove clearly that arterialization is really able to minimize the risk of encephalopathy and to prolong the lopgterm survival after portacaval shunt.
T HE SURGICAL DECOMPRESSION of portal hypertension is not infrequently associated with a progressive deterioration of hepatic function. During the last 15 years, two different approaches have been explored to avoid these complications: selective decompression of oesophageal varices and arterialization of the portal vein.
Arterialization of the hepatic stump of the portal vein in conjunction with end-to-side portacaval shunt is Submitted for publication: February 18, 1982. From the Departments of Surgery, Intensive care, Gastro- enterology and Anesthesiology and the Laboratory of Surgical Research, University of Louvain, Cliniques SaintLuc, Brussel, Belgium based on the hypothesis that the increased incidence of hepatic failure after portosystemic shunting is at least partly related to the abrupt decrease of the total hepatic blood flow." Indeed, some clinical reports have suggested that the incidence of postshunt encephalopathy was effectively decreased after arterialization.2 ""'5 However, the reported experience ofthis procedure is limited to a few hundred cases,2"5 and several questions should be answered before a wider clinical application is recommended. Firstly, the indications for arterialization should be more precisely defined on a hemodynamic basis, since a wide range of residual portal flow is observed in cirrhotic patients,'3 and the compensation of the hepatic artery following end-to-side portacaval shunt is unpredictable from preoperative data.4 Secondly, practical means should be available to the surgeon to prevent arterialization from exceeding the initial portal pressure and flow since histologic damage to the liver parenchyma has resulted, in experimental animals, from an excessive arterial inflow into the intrahepatic portal bed.'7 Thirdly, more information is needed about the influence of arterialization on the operative risk of portacaval shunt, both in emergency and electively, and also on the long-term survival; potential complications should be known. An answer to these questions is brought at least partly by the retrospective study ofthe authors' experience with 75 patients operated on between September 1973 and May 1979; hemodynamic investigations, operative techniques, early and late mortality, complications, and results are described. According to the data collected in (Table 3 ) had a mean portal flow of 484 ± 41 ml/min., a mean maximum perfusion pressure of 19.8 ± 1.37 cm H20 and a mean portal perfusion pressure of 8.6 ± 0.72 cm H20. Maximum perfusion pressure was correlated (r = 0.668, p < 0.001) with the portal flow. In a subgroup of 33 patients in whom the simultaneous measurement of CSP was achieved, ACSP was also found to be correlated (r = 0.72, p < 0.001) with the portal flow. Among these 61 patients who had a direct portal flow measurement, 49 were classified into the hepatopedal portal flow group (group a) and 12 into the stagnant portal flow group (Table 4) .
In the 13 patients not submitted to direct flow measurement, the maximum perfusion pressure ranged from 10 to 30 cm H20 (mean: 20.9 ± 1.75) and the portal perfusion pressure from 5 to 18 cm H20 (mean: 11 ± 1.32) in 12 patients, while the last patient had negative (-3 cm H20) MPP and PPP; these 12 patients (group b) were allocated to the hepatopedal portal flow group on the basis of the correlation observed between MPP and portal flow in the 61 patients whose flow was directly measured; for the same reason, the remaining patient was allocated to the stagnant portal flow group. In summary, 61 patients* were considered to have a hepatopedal portal flow and were submitted to arterialization * In order to avoid misunderstanding, the fact should be stressed that the 61 patients who were considered to have a hepatopedal portal flow (groups a and b) are not the same as the 61 patients whose portal flow was measured directly with the flowmeter. Total hepatic bloodflow before and after arterialization. The data of the total hepatic blood flow measured in six patients before and after portacaval shunt and arterialization are listed in table 6. Despite the small number of data and individual variations, they indicate that arterialization in these six patients restored the total hepatic blood flow at a slightly lower level than preshunt values. About two thirds of the portal vein flow measured before shunting were delivered to the liver through the arterialization while a substantial increase ofthe flow through the hepatic artery was observed in three patients despite arterialization.
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Operative Mortality.
The operative mortality was 16% for the whole group of 75 patients, 11.2% (7 out Patients Massive and intractable ascites developed in six patients either immediately (three patients) or during the second or the third postoperative week (three patients); only one of these patients had ascites before operation. The patency of PC shunt and venous graft was proved by angiography in all instances. The CSP was recorded repeatedly; in comparison with the preoperative value, it had increased considerably in five patients, reaching at least twice the preoperative level, while it had decreased in one patient. The five patients with an increased CSP were surgically re-explored between day one and day 16; the flow through the venous graft was found to have approximately doubled in each patient. The venous graft was ligated in three patients and narrowed by a banding in two patients. The first patient encoun-60 40 20 tered with this complication died shortly after reoperation; the other patients were cured of ascites and survived the complication. In the sixth patient with a decreased CSP, a Leveen shunt was placed at 16 months with a good result. Transient ascites was observed in four patients between the first postoperative day and the sixth week. A nonsurgical cause was identified in every case and responded to medical treatment in three cases; one patient with hepatic failure died. None of these patients showed a significant increase of CSP; vascular anastomoses were patent in all instances.
Severe jaundice, exceeding 10 mg % of serum bilirubine, was observed in eleven patients, either in the early postoperative period (six patients) or later between three weeks and six months (five patients). The jaundice resulted from acute viral B hepatitis in two patients and from non-A non-B acute hepatitis in two patients (with two deaths). Progressive hepatic failure leading to hepatic coma and death was observed in six patients; in three of these, hepatic failure was possibly precipitated by hyperarterialization. Alcoholism was also responsible for severe jaundice in one patient; cure followed abstinence.
Discussion
The world experience of arterialization of the portal vein in conjunction with a portacaval shunt that was collected in 1977 by Adamsons2 amounted to 246 cases (including the authors' first 14 cases)'5 among which only 24 had been operated on in emergency conditions. By May 1979, the authors' own experience had been extended to the 62 cases that form the basis of this report. In the collected series, the operative mortality of arterialization averaged 17% after elective surgery; the influence of this procedure on hospital mortality in emergency situations and on long-term survival was unknown, owing to the lack of detailed studies and the small number of cases.
In the authors' experience, arterialization did not increase the low operative mortality of elective cases, but it significantly reduced the operative mortality in emergency (14.8%) which used to be much higher in the authors' previous experience23 and averaged 40% in several reported series of the standard portacaval shunt.8"2"4 However, the operative mortality remained prohibitive in class C patients despite concomitant arterialization; therefore these patients are now treated in this institution by endoscopic sclerosis of oesophageal varices.
The addition of arterialization to portacaval shunting undoubtedly increases the operative trauma and the length of operation; nevertheless, no postoperative death was directly attributed to the procedure itself in the col-661 lective reviews of Maillard" and Adamsons,2 with the exception of one case of Maillard. In the authors' own series, arterialization "per se" contributed to death in a single patient owing to the delayed recognition that intractable ascites was possibly related to secondary increase of the flow through the venous prosthesis. Arterialization can thus be considered as a safe surgical procedure.
Up to now, no data have been published concerning the long-term survival of arterialized patients. The fiveyear survival rate of the 62 patients (operative deaths included) is 48%; it reaches 56% for class A and B patients operated on in elective conditions. The only, but still disputable, comparison could be made with the three controlled series7"8'2' of the therapeutic portacaval shunt whose data combined by Conn5 gave a survival rate of about 44% after four years; a slight improvement in long-term survival could be observed in the series of arterialized patients despite a much higher proportion of class C patients (17%) and emergency operations (43%) than in the controlled studies. Reduction of postshunt encephalopathy has been the major purpose of the various teams involved in clinical arterialization. Maillard" and Adamsons2 have presented encouraging results; the incidence of 27% that was observed among 55 surviving patients is lower than that reported by Jackson et al., 7 Resnick et al., '8 and Rueff et al.2' in their randomized studies (respectively, 34, 50, and 41%). However the authors' follow-up is shorter, and it is well known that the incidence of postshunt encephalopathy increases with time. Whether arterialization really minimizes the risk ofencephalopathy and prolongs the longterm survival could be clarified only by a prospective randomized study such as the one undertaken in December 1979.
The purpose of arterialization is the prevention of an abrupt decrease in hepatic blood flow, but this rationale has often been questioned inasmuch as there seems to be no correlation between the extent of preshunt portal flow and either the hospital or long-term mortality or the incidence of portal systemic encephalopathy, as shown by Burchell et al. 3 Moreover the same authors4 have shown that the increment in arterial flow was the only hemodynamic variable directly related to morbidity, hospital mortality and long-term survival. This observation, however, supports the view that residual total hepatic blood flow after a PC shunt has some bearing on the tolerance to the operation, and it implies that arterialization of the portal vein could be beneficial for at least those patients whose arterial flow does not increase adequately in response to the relief of sinusoidal hypertension. That hepatic arterial flow can fail to increase commensurately with the diverted portal flow is demonstrated by the correlation (r = 0.72), observed in 33 of the patients, between the portal flow and the peroperative reduction of the corrected sinusoidal pressure in response to the occlusion of the portal vein. Furthermore, the data obtained in a few of the cases in which the hepatic artery flow was measured (Table 6) suggest that arterialization of the portal vein limits but does not preclude the increase of the flow through the hepatic artery; detailed peroperative flow measurements made in more recent cases appear to confirm this observation.
The authors share Adamsons' opinion2 that arterialization is indicated when hepatopedal portal flow has been proven by peroperative hemodynamic investigations; the lack of rationale and the fear of complications have led to the avoidance of arterialization in patients with a spontaneous reversal of portal flow. Since excessive arterialization has to be avoided as shown by experimental studies,'7 peroperative hemodynamic investigations should comprise reliable evaluation of both the residual portal flow and the arterial flow subsequently restored into the intrahepatic portal bed.
In order to avoid occasional errors, the authors think that direct flow measurement should be completed by pressure studies. Maximum perfusion pressure is an indirect but easily available method for evaluating the portal flow; its value has been denied by Burchell and coworkers3 but the authors' own data in 61 patients have shown a correlation (r = 0.66) between MPP and the portal flow measured with the flowmeter. It is hard to explain the contradiction between these two studies that concern similar numbers of patients except that some electromagnetic measurements might have been erroneous as suggested by Burchell and coworkers.3 In the authors' experience, the peroperative recording of the CSP also gives an evaluation of the portal flow which was found in 33 patients to be in correlation (r = 0.72) with the reduction of CSP induced by the occlusion of the portal vein.
To prevent postoperative complications and further damage to the cirrhotic liver and to allow adaptation of the hepatic artery, great attention was paid in this series to limit the arterial flow into the intrahepatic portal bed to about two thirds of the pre-existing portal flow.
To attain this purpose, banding of the prosthesis was required in 16 patients before termination of the operation. Despite the precautions that were taken during surgery, several patients developed postoperative complications that were possibly related to progressive increase of the flow through the prosthesis. Intractable ascites were observed in five patients with a considerable increase of CSP over the peroperative values; re-exploration showed that the flow through the venous prosthesis had approximately doubled by comparison with the values recorded at the end of the first operation. Reduction of the flow achieved by total or partial ligation of the prosthesis was followed by disappearance of ascites and the cure of four patients. A cholostatic type jaundice was observed by Maillard'°in one patient whose blood pressure in the prosthesis had increased from 20 mmHg at the first operation to 40 mmHg at the second. Reduction of the pressure by partial ligation of the prosthesis was followed by a rapid decrease of jaundice. The authors experienced the same complication in one patient, and the banding of the prosthesis also resulted in a steep decrease of jaundice over the next days. Maillard" reported that there was no relation between increase in sinusoidal pressure and increase in total hepatic blood flow. In the authors' experience however, increase in sinusoidal pressure has been a useful guide for detecting excessive arterialization when intractable ascites or cholostatic jaundice developed after operation. If arterialization is the elected procedure for preventing the decrease in total hepatic blood flow resulting from decompression of the portal bed, the authors suggest that besides the peroperative hemodynamic investigations that are mandatory, sinusoidal pressure should be monitored after operation and repeatedly measured in case of complications possibly related to excessive arterialization.
